NASDAQ:XBIT | Key Financial Ratios | XBiotech Inc.

Complete source-backed ratio history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3033.15-33.77%-35.13%
2026-03-3139.03-28.72%-29.75%
2025-12-3116.01-30.34%-32.45%
2025-09-3041.78-16.91%-17.45%
2025-06-3040.16-15.76%-16.27%
2025-03-3129.15-21.67%-22.56%
2024-12-3111.56-19.35%-21.14%
2024-09-3011.57-15.56%-17.00%
2024-06-3011.13-16.24%-17.80%
2024-03-3112.03-13.49%-14.69%
2023-12-3133.07-10.84%-11.22%
2023-09-3038.61-10.07%-10.39%
2023-06-3047.08-12.09%-12.41%
2023-03-3159.78-12.94%-13.22%
2022-12-3154.07-13.37%-13.69%
2022-09-3062.44-14.42%-14.77%
2022-06-3028.99-10.05%-10.46%
2022-03-3184.05-7.47%-7.62%
2021-12-3171.49-6.33%-6.46%
2021-09-3064.81-4.57%-4.66%
2021-06-3083.49-3.40%-3.46%
2021-03-31120.51-3.87%-3.91%
2020-12-3181.8-3.17%-3.22%
2020-09-3040.61191.60%195.62%
2020-06-3018.28187.73%196.03%
2020-03-3125.2188.21%194.33%
2019-12-3111.981.85%88.49%
2019-09-3020.24-35.98%-37.10%
2019-06-3018.52-31.83%-32.96%
2019-03-314.57-57.59%-62.01%
2018-12-315.78-47.67%-51.06%
2018-09-309.26-45.24%-47.46%
2018-06-309.35-43.16%-45.48%
2018-03-3112.22-45.29%-47.25%
2017-12-3111.94-52.64%-55.10%
2017-09-3011.5-59.85%-62.99%
2017-06-3010.14-62.41%-66.40%
2017-03-3110.72-60.57%-64.50%
2016-12-314.64-78.69%-89.33%
2016-09-307.35-61.63%-67.36%
2016-06-306.39-49.90%-56.16%
2016-03-3112.17-39.13%-41.85%
2015-12-3114.79-34.28%-36.37%
2015-09-3021.7-26.83%-28.00%
2015-06-3042.01-22.21%-22.72%
2015-03-3114.05-43.17%-46.18%
2014-12-3118.45-34.94%-36.80%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-3116.01-30.34%-32.45%
2024-12-3111.56-19.35%-21.14%
2023-12-3133.07-10.84%-11.22%
2022-12-3154.07-13.37%-13.69%
2021-12-3171.49-6.33%-6.46%
2020-12-3181.8-3.17%-3.22%
2019-12-3111.981.85%88.49%
2018-12-315.78-47.67%-51.06%
2017-12-3111.94-52.64%-55.10%
2016-12-314.64-78.69%-89.33%
2015-12-3114.79-34.28%-36.37%
2014-12-3118.45-34.94%-36.80%
2013-12-31-97.06%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.